dnmt1 (cat Search Results


96
Thermo Fisher gene exp dnmt1 mm01151063 m1
Bulk RNA-seq of flow-sorted APC CD24 + progenitors and CD24 − preadipocytes reveals transcriptomic signatures for adipogenic, mitochondrial, and energetics pathways by low n6/n3 FA ratios (A) Differential gene expression by n6/n3 exposure group within either progenitor or preadipocyte APC subtypes was analyzed using comparative analysis in Ingenuity Pathway Analysis. Significantly enriched canonical pathways in common between CD24 + progenitor and CD24 − preadipocyte APCs were ordered by FDR p value (≤0.01) and colored by the predicted activation Z score. Coloring indicates common pathways predicted to be “on” (yellow), “off” (navy), or “no prediction” (white) due to low n6/n3 exposure. Pathway activation Z score values are presented for either APC subtype, and values ≥2.0 or ≤ −2.0 are considered significant. (B) Significantly different genes in either CD24 + progenitor or CD24 − preadipocyte relative to the high n6/n3 FA ratio group colored by Log2 fold change and grouped into transcription factor genes (Regulatory) and signal transduction pathway genes (Ligands/Kinases). (C) Significantly different lipid metabolism, mitochondrial, and glycolytic genes indicating that the low n6/n3 FA ratio changes oxidative capacity potentially through aldehyde dehydrogenases (Aldh1a1 and Aldh1a3), uncoupling protein 2 (Ucp2), citrate synthase (CS), isocitrate dehydrogenase (Idh1 and 2), malic enzyme (Me1), malate dehydrogenase (Mdh1), phosphofructokinases (Pfkm, Pfkp, and Pfkfb1), and transketolase (Tk) (See also <xref ref-type=Figure S2 ). (D) Canonical Pathway enrichment within either CD24 + progenitor or CD24 − preadipocyte APCs plotted by the percentage DE-Gs within a pathway (%) by the pathway enrichment significance (-log(p value)) and colored by the predicted pathway activation ( Z score, >2.0 and < −2.0 was considered significant) (See also for all pathways). (E) Immunoblots for NR2F2, UCP2, C/EBPα, and DNMT1 from all lineage negative, CD29+/CD34+, and Sca1+ APCs isolated by flow cytometry from pooled litters (n = 3 litter dyads per n6/n3 FA ratio group; litters standardized to 6-8 pups/litter). (F) EVC005 murine APC cell line was treated with and without NR2F2 ligand 1-DSO for 48 h, which induced gene expression of Prdm16, P2rx5, Runx1, Ucp2, Dnmt1, Pparγ2, and C/ebpα. (G) TMRE live cell mitochondrial potential dye following 48 h of 1-DSO treatment in EVC005 cells, indicating an increased mitochondrial potential. Panels F and G are n = 3 wells per treatment group. Scale bar represents 50 μm. Data are represented as mean ± SEM. " width="250" height="auto" />
Gene Exp Dnmt1 Mm01151063 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dnmt1+%28cat/pmc09800552-78-9-5?v=Thermo+Fisher
Average 96 stars, based on 1 article reviews
gene exp dnmt1 mm01151063 m1 - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology dnmt1 sirna
Regulation of Rac1 gene transcripts and 5hmC at its promoter. Cells transfected with Suv39H1 -siRNA ( Suv -si) or <t>Dnmt1</t> -siRNA ( Dnmt -si), incubated in high glucose for four days, were analyzed for Rac1 ( a ) gene transcripts by qRT-PCR using β-actin as a housekeeping gene and ( b ) 5hmC at its promoter by immunoprecipitating 5hmC in the genomic DNA , and quantifying by qRT-PCR using gene specific primers. Transfection efficiency of ( c ) SuvH39H1 -siRNAs and ( d ) Dnmt1 -siRNA was determined by quantifying its gene transcripts. NG and HG = cells in 5 mM or 20 mM D-glucose respectively, HG/ Suv -si and HG/ Dnmt1 -si = cells transfected with Suv39H1 -siRNA or Dnmt1 -siRNA, and incubated in 20 mM D-glucose, Suv -si and Dnmt -si = cells transfected with Suv39H1 -siRNA or Dnmt1 -siRNA. * p < 0.05 vs NG and # p < 0.05 vs HG.
Dnmt1 Sirna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dnmt1+%28cat/pmc08266843-147-43-48?v=Santa+Cruz+Biotechnology
Average 93 stars, based on 1 article reviews
dnmt1 sirna - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

90
ProSci Incorporated anti chicken igy for dnmt1
Regulation of Rac1 gene transcripts and 5hmC at its promoter. Cells transfected with Suv39H1 -siRNA ( Suv -si) or <t>Dnmt1</t> -siRNA ( Dnmt -si), incubated in high glucose for four days, were analyzed for Rac1 ( a ) gene transcripts by qRT-PCR using β-actin as a housekeeping gene and ( b ) 5hmC at its promoter by immunoprecipitating 5hmC in the genomic DNA , and quantifying by qRT-PCR using gene specific primers. Transfection efficiency of ( c ) SuvH39H1 -siRNAs and ( d ) Dnmt1 -siRNA was determined by quantifying its gene transcripts. NG and HG = cells in 5 mM or 20 mM D-glucose respectively, HG/ Suv -si and HG/ Dnmt1 -si = cells transfected with Suv39H1 -siRNA or Dnmt1 -siRNA, and incubated in 20 mM D-glucose, Suv -si and Dnmt -si = cells transfected with Suv39H1 -siRNA or Dnmt1 -siRNA. * p < 0.05 vs NG and # p < 0.05 vs HG.
Anti Chicken Igy For Dnmt1, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dnmt1+%28cat/10__1262_slash_jrd__09___105A-139-18-27?v=ProSci+Incorporated
Average 90 stars, based on 1 article reviews
anti chicken igy for dnmt1 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
ABclonal Biotechnology dnmt1 (cat#a22455)
Regulation of Rac1 gene transcripts and 5hmC at its promoter. Cells transfected with Suv39H1 -siRNA ( Suv -si) or <t>Dnmt1</t> -siRNA ( Dnmt -si), incubated in high glucose for four days, were analyzed for Rac1 ( a ) gene transcripts by qRT-PCR using β-actin as a housekeeping gene and ( b ) 5hmC at its promoter by immunoprecipitating 5hmC in the genomic DNA , and quantifying by qRT-PCR using gene specific primers. Transfection efficiency of ( c ) SuvH39H1 -siRNAs and ( d ) Dnmt1 -siRNA was determined by quantifying its gene transcripts. NG and HG = cells in 5 mM or 20 mM D-glucose respectively, HG/ Suv -si and HG/ Dnmt1 -si = cells transfected with Suv39H1 -siRNA or Dnmt1 -siRNA, and incubated in 20 mM D-glucose, Suv -si and Dnmt -si = cells transfected with Suv39H1 -siRNA or Dnmt1 -siRNA. * p < 0.05 vs NG and # p < 0.05 vs HG.
Dnmt1 (Cat#A22455), supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dnmt1+%28cat/pm39119834-323-0-16?v=ABclonal+Biotechnology
Average 90 stars, based on 1 article reviews
dnmt1 (cat#a22455) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

92
Novus Biologicals anti dnmt1 mouse monoclonal dnmt1
Figure 1. 5hmC content is diluted during replication. A. Hemi-hydroxymethylated DNA (CG/5hmCG) is not a good substrate for <t>Dnmt1.</t> The DNA methylation activity of mouse Dnmt1, Dnmt3a, and Dnmt3b towards 35-bp unmethylated (CG/CG), hemi- methylated (CG/5mCG), or hemi-hydroxymethylated (CG/5hmCG) DNA was determined. B. Gel mobility shift assaying of the SRA domain of mouse Uhrf1. The indicated concentrations of SRA were incubated with either 12-bp CG/5mC, CG/5hmCG, or CG/CG, followed by electrophoresis (left panel). The complex of the SRA and 32P-labeled CG/5mCG was competed with the indicated amounts of non-labeled CG/5mCG, CG/5hmCG, or CG/CG DNA (right panel). DNA bound to SRA (B) and free DNA (F) are indicated.
Anti Dnmt1 Mouse Monoclonal Dnmt1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dnmt1+%28cat/pm24340069-113-18-27?v=Novus+Biologicals
Average 92 stars, based on 1 article reviews
anti dnmt1 mouse monoclonal dnmt1 - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier

90
EpiGentek epiquik dnmt1 assay kit (cat. no. p-3011-2)
Figure 1. 5hmC content is diluted during replication. A. Hemi-hydroxymethylated DNA (CG/5hmCG) is not a good substrate for <t>Dnmt1.</t> The DNA methylation activity of mouse Dnmt1, Dnmt3a, and Dnmt3b towards 35-bp unmethylated (CG/CG), hemi- methylated (CG/5mCG), or hemi-hydroxymethylated (CG/5hmCG) DNA was determined. B. Gel mobility shift assaying of the SRA domain of mouse Uhrf1. The indicated concentrations of SRA were incubated with either 12-bp CG/5mC, CG/5hmCG, or CG/CG, followed by electrophoresis (left panel). The complex of the SRA and 32P-labeled CG/5mCG was competed with the indicated amounts of non-labeled CG/5mCG, CG/5hmCG, or CG/CG DNA (right panel). DNA bound to SRA (B) and free DNA (F) are indicated.
Epiquik Dnmt1 Assay Kit (Cat. No. P 3011 2), supplied by EpiGentek, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dnmt1+%28cat/pmc05768662-485-10-28?v=EpiGentek
Average 90 stars, based on 1 article reviews
epiquik dnmt1 assay kit (cat. no. p-3011-2) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Abnova dnmt1
Methylation-dependent silencing of KDM2B expression. (A) LCL were cultured for 96 h in the presence of DMSO (nontreated [NT]) or 5-aza-2′-deoxycytidine (Aza). Cells were then collected, and the KDM2B expression levels were analyzed by RT-qPCR. The histogram shows the average KDM2B mRNA levels measured in 3 independent experiments (*, P < 0.05). KDM2B mRNA levels in Aza-treated LCL were measured relative to its levels in DMSO-treated cells. (B) LCL were transfected with stabilized siRNA targeting <t>DNMT1</t> (siDNMT1) in two independent experiments. At 4 days after transfection, cells were collected and analyzed for the protein levels of DNMT1 (top) and the mRNA levels of KDM2B (bottom). KDM2B mRNA levels in DNMT1-targeted siRNA-treated cells were measured relative to its levels in cells treated with scrambled (scr) siRNA. (C) RPMI cells infected with EBV or mock infected were fixed and processed for ChIP with a DNMT1 antibody or an IgG antibody as a negative control. The eluted DNA was analyzed by qPCR with primers flanking CpG15695155, CpG21423404, and CpG island 127 (primer sequences are described in Table 3) (*, P < 0.05; ns, not significant).
Dnmt1, supplied by Abnova, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dnmt1+%28cat/pmc06580945-678-10-14?v=Abnova
Average 90 stars, based on 1 article reviews
dnmt1 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

93
Novus Biologicals anti dnmt1
Methylation-dependent silencing of KDM2B expression. (A) LCL were cultured for 96 h in the presence of DMSO (nontreated [NT]) or 5-aza-2′-deoxycytidine (Aza). Cells were then collected, and the KDM2B expression levels were analyzed by RT-qPCR. The histogram shows the average KDM2B mRNA levels measured in 3 independent experiments (*, P < 0.05). KDM2B mRNA levels in Aza-treated LCL were measured relative to its levels in DMSO-treated cells. (B) LCL were transfected with stabilized siRNA targeting <t>DNMT1</t> (siDNMT1) in two independent experiments. At 4 days after transfection, cells were collected and analyzed for the protein levels of DNMT1 (top) and the mRNA levels of KDM2B (bottom). KDM2B mRNA levels in DNMT1-targeted siRNA-treated cells were measured relative to its levels in cells treated with scrambled (scr) siRNA. (C) RPMI cells infected with EBV or mock infected were fixed and processed for ChIP with a DNMT1 antibody or an IgG antibody as a negative control. The eluted DNA was analyzed by qPCR with primers flanking CpG15695155, CpG21423404, and CpG island 127 (primer sequences are described in Table 3) (*, P < 0.05; ns, not significant).
Anti Dnmt1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dnmt1+%28cat/pmc12957900-95-50-52?v=Novus+Biologicals
Average 93 stars, based on 1 article reviews
anti dnmt1 - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

95
Santa Cruz Biotechnology mouse anti dnmt1 monoclonal antibody mab
Methylation-dependent silencing of KDM2B expression. (A) LCL were cultured for 96 h in the presence of DMSO (nontreated [NT]) or 5-aza-2′-deoxycytidine (Aza). Cells were then collected, and the KDM2B expression levels were analyzed by RT-qPCR. The histogram shows the average KDM2B mRNA levels measured in 3 independent experiments (*, P < 0.05). KDM2B mRNA levels in Aza-treated LCL were measured relative to its levels in DMSO-treated cells. (B) LCL were transfected with stabilized siRNA targeting <t>DNMT1</t> (siDNMT1) in two independent experiments. At 4 days after transfection, cells were collected and analyzed for the protein levels of DNMT1 (top) and the mRNA levels of KDM2B (bottom). KDM2B mRNA levels in DNMT1-targeted siRNA-treated cells were measured relative to its levels in cells treated with scrambled (scr) siRNA. (C) RPMI cells infected with EBV or mock infected were fixed and processed for ChIP with a DNMT1 antibody or an IgG antibody as a negative control. The eluted DNA was analyzed by qPCR with primers flanking CpG15695155, CpG21423404, and CpG island 127 (primer sequences are described in Table 3) (*, P < 0.05; ns, not significant).
Mouse Anti Dnmt1 Monoclonal Antibody Mab, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dnmt1+%28cat/pmc05356578-150-6-16?v=Santa+Cruz+Biotechnology
Average 95 stars, based on 1 article reviews
mouse anti dnmt1 monoclonal antibody mab - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier

94
Novus Biologicals nb100
Methylation-dependent silencing of KDM2B expression. (A) LCL were cultured for 96 h in the presence of DMSO (nontreated [NT]) or 5-aza-2′-deoxycytidine (Aza). Cells were then collected, and the KDM2B expression levels were analyzed by RT-qPCR. The histogram shows the average KDM2B mRNA levels measured in 3 independent experiments (*, P < 0.05). KDM2B mRNA levels in Aza-treated LCL were measured relative to its levels in DMSO-treated cells. (B) LCL were transfected with stabilized siRNA targeting <t>DNMT1</t> (siDNMT1) in two independent experiments. At 4 days after transfection, cells were collected and analyzed for the protein levels of DNMT1 (top) and the mRNA levels of KDM2B (bottom). KDM2B mRNA levels in DNMT1-targeted siRNA-treated cells were measured relative to its levels in cells treated with scrambled (scr) siRNA. (C) RPMI cells infected with EBV or mock infected were fixed and processed for ChIP with a DNMT1 antibody or an IgG antibody as a negative control. The eluted DNA was analyzed by qPCR with primers flanking CpG15695155, CpG21423404, and CpG island 127 (primer sequences are described in Table 3) (*, P < 0.05; ns, not significant).
Nb100, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dnmt1+%28cat/pm37270777-185-98-95?v=Novus+Biologicals
Average 94 stars, based on 1 article reviews
nb100 - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

90
ProteoGenix mouse monoclonal anti-dnmt1
TIP60 interferes with UHRF1-USP7 association and their expression levels. HeLa cells were transfected with either TIP60-eGFP WT or TIP60ΔMYST-eGFP mutant. Western blot and immunoprecipitated samples were resolved by SDS-PAGE and immunoblotted with anti-UHRF1, anti-USP7 <t>and</t> <t>anti-DNMT1</t> antibodies. (A) Effect of TIP60 on UHRF1, USP7 and DNMT1 levels with or without MG-132 treatment, respectively. (B and C) Quantification of the effect of TIP60 on UHRF1, USP7 and DNMT1 levels with or without MG-132 treatment, respectively. Values are the mean ± SEM from at least three independent experiments which were analyzed statistically by one-way ANOVA with Tukey's post hoc test ( * P<0.05; *** P<0.001 vs. control group). (D) Anti-UHRF1 antibody was used to co-immunoprecipitate UHRF1 and its partner USP7. (E) In a reciprocal experiment, anti-USP7 antibody was used to co-immunoprecipitate USP7 and UHRF1. Inputs and IP gels were processed in parallel under similar conditions. UHRF1, ubiquitin-like, containing PHD and RING finger domains 1; TIP60, Tat interactive protein, 60 kDa; USP7, ubiquitin-specific-processing protease 7; DNMT1, DNA methyltransferase 1.
Mouse Monoclonal Anti Dnmt1, supplied by ProteoGenix, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dnmt1+%28cat/pmc08480382-51-12-19?v=ProteoGenix
Average 90 stars, based on 1 article reviews
mouse monoclonal anti-dnmt1 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

95
Proteintech dnmt1
TIP60 interferes with UHRF1-USP7 association and their expression levels. HeLa cells were transfected with either TIP60-eGFP WT or TIP60ΔMYST-eGFP mutant. Western blot and immunoprecipitated samples were resolved by SDS-PAGE and immunoblotted with anti-UHRF1, anti-USP7 <t>and</t> <t>anti-DNMT1</t> antibodies. (A) Effect of TIP60 on UHRF1, USP7 and DNMT1 levels with or without MG-132 treatment, respectively. (B and C) Quantification of the effect of TIP60 on UHRF1, USP7 and DNMT1 levels with or without MG-132 treatment, respectively. Values are the mean ± SEM from at least three independent experiments which were analyzed statistically by one-way ANOVA with Tukey's post hoc test ( * P<0.05; *** P<0.001 vs. control group). (D) Anti-UHRF1 antibody was used to co-immunoprecipitate UHRF1 and its partner USP7. (E) In a reciprocal experiment, anti-USP7 antibody was used to co-immunoprecipitate USP7 and UHRF1. Inputs and IP gels were processed in parallel under similar conditions. UHRF1, ubiquitin-like, containing PHD and RING finger domains 1; TIP60, Tat interactive protein, 60 kDa; USP7, ubiquitin-specific-processing protease 7; DNMT1, DNA methyltransferase 1.
Dnmt1, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dnmt1+%28cat/pm39450540-150-33-38?v=Proteintech
Average 95 stars, based on 1 article reviews
dnmt1 - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier

Image Search Results


Bulk RNA-seq of flow-sorted APC CD24 + progenitors and CD24 − preadipocytes reveals transcriptomic signatures for adipogenic, mitochondrial, and energetics pathways by low n6/n3 FA ratios (A) Differential gene expression by n6/n3 exposure group within either progenitor or preadipocyte APC subtypes was analyzed using comparative analysis in Ingenuity Pathway Analysis. Significantly enriched canonical pathways in common between CD24 + progenitor and CD24 − preadipocyte APCs were ordered by FDR p value (≤0.01) and colored by the predicted activation Z score. Coloring indicates common pathways predicted to be “on” (yellow), “off” (navy), or “no prediction” (white) due to low n6/n3 exposure. Pathway activation Z score values are presented for either APC subtype, and values ≥2.0 or ≤ −2.0 are considered significant. (B) Significantly different genes in either CD24 + progenitor or CD24 − preadipocyte relative to the high n6/n3 FA ratio group colored by Log2 fold change and grouped into transcription factor genes (Regulatory) and signal transduction pathway genes (Ligands/Kinases). (C) Significantly different lipid metabolism, mitochondrial, and glycolytic genes indicating that the low n6/n3 FA ratio changes oxidative capacity potentially through aldehyde dehydrogenases (Aldh1a1 and Aldh1a3), uncoupling protein 2 (Ucp2), citrate synthase (CS), isocitrate dehydrogenase (Idh1 and 2), malic enzyme (Me1), malate dehydrogenase (Mdh1), phosphofructokinases (Pfkm, Pfkp, and Pfkfb1), and transketolase (Tk) (See also <xref ref-type=Figure S2 ). (D) Canonical Pathway enrichment within either CD24 + progenitor or CD24 − preadipocyte APCs plotted by the percentage DE-Gs within a pathway (%) by the pathway enrichment significance (-log(p value)) and colored by the predicted pathway activation ( Z score, >2.0 and < −2.0 was considered significant) (See also for all pathways). (E) Immunoblots for NR2F2, UCP2, C/EBPα, and DNMT1 from all lineage negative, CD29+/CD34+, and Sca1+ APCs isolated by flow cytometry from pooled litters (n = 3 litter dyads per n6/n3 FA ratio group; litters standardized to 6-8 pups/litter). (F) EVC005 murine APC cell line was treated with and without NR2F2 ligand 1-DSO for 48 h, which induced gene expression of Prdm16, P2rx5, Runx1, Ucp2, Dnmt1, Pparγ2, and C/ebpα. (G) TMRE live cell mitochondrial potential dye following 48 h of 1-DSO treatment in EVC005 cells, indicating an increased mitochondrial potential. Panels F and G are n = 3 wells per treatment group. Scale bar represents 50 μm. Data are represented as mean ± SEM. " width="100%" height="100%">

Journal: iScience

Article Title: Neonatal intake of Omega-3 fatty acids enhances lipid oxidation in adipocyte precursors

doi: 10.1016/j.isci.2022.105750

Figure Lengend Snippet: Bulk RNA-seq of flow-sorted APC CD24 + progenitors and CD24 − preadipocytes reveals transcriptomic signatures for adipogenic, mitochondrial, and energetics pathways by low n6/n3 FA ratios (A) Differential gene expression by n6/n3 exposure group within either progenitor or preadipocyte APC subtypes was analyzed using comparative analysis in Ingenuity Pathway Analysis. Significantly enriched canonical pathways in common between CD24 + progenitor and CD24 − preadipocyte APCs were ordered by FDR p value (≤0.01) and colored by the predicted activation Z score. Coloring indicates common pathways predicted to be “on” (yellow), “off” (navy), or “no prediction” (white) due to low n6/n3 exposure. Pathway activation Z score values are presented for either APC subtype, and values ≥2.0 or ≤ −2.0 are considered significant. (B) Significantly different genes in either CD24 + progenitor or CD24 − preadipocyte relative to the high n6/n3 FA ratio group colored by Log2 fold change and grouped into transcription factor genes (Regulatory) and signal transduction pathway genes (Ligands/Kinases). (C) Significantly different lipid metabolism, mitochondrial, and glycolytic genes indicating that the low n6/n3 FA ratio changes oxidative capacity potentially through aldehyde dehydrogenases (Aldh1a1 and Aldh1a3), uncoupling protein 2 (Ucp2), citrate synthase (CS), isocitrate dehydrogenase (Idh1 and 2), malic enzyme (Me1), malate dehydrogenase (Mdh1), phosphofructokinases (Pfkm, Pfkp, and Pfkfb1), and transketolase (Tk) (See also Figure S2 ). (D) Canonical Pathway enrichment within either CD24 + progenitor or CD24 − preadipocyte APCs plotted by the percentage DE-Gs within a pathway (%) by the pathway enrichment significance (-log(p value)) and colored by the predicted pathway activation ( Z score, >2.0 and < −2.0 was considered significant) (See also for all pathways). (E) Immunoblots for NR2F2, UCP2, C/EBPα, and DNMT1 from all lineage negative, CD29+/CD34+, and Sca1+ APCs isolated by flow cytometry from pooled litters (n = 3 litter dyads per n6/n3 FA ratio group; litters standardized to 6-8 pups/litter). (F) EVC005 murine APC cell line was treated with and without NR2F2 ligand 1-DSO for 48 h, which induced gene expression of Prdm16, P2rx5, Runx1, Ucp2, Dnmt1, Pparγ2, and C/ebpα. (G) TMRE live cell mitochondrial potential dye following 48 h of 1-DSO treatment in EVC005 cells, indicating an increased mitochondrial potential. Panels F and G are n = 3 wells per treatment group. Scale bar represents 50 μm. Data are represented as mean ± SEM.

Article Snippet: Dnmt1 mouse TaqMan Primer , ThermoFisher Scientific , Cat# Mm01151063_m1.

Techniques: RNA Sequencing, Gene Expression, Activation Assay, Transduction, Western Blot, Isolation, Flow Cytometry

Journal: iScience

Article Title: Neonatal intake of Omega-3 fatty acids enhances lipid oxidation in adipocyte precursors

doi: 10.1016/j.isci.2022.105750

Figure Lengend Snippet:

Article Snippet: Dnmt1 mouse TaqMan Primer , ThermoFisher Scientific , Cat# Mm01151063_m1.

Techniques: Recombinant, High Molecular Weight, Enzyme-linked Immunosorbent Assay, Software, Modification

Regulation of Rac1 gene transcripts and 5hmC at its promoter. Cells transfected with Suv39H1 -siRNA ( Suv -si) or Dnmt1 -siRNA ( Dnmt -si), incubated in high glucose for four days, were analyzed for Rac1 ( a ) gene transcripts by qRT-PCR using β-actin as a housekeeping gene and ( b ) 5hmC at its promoter by immunoprecipitating 5hmC in the genomic DNA , and quantifying by qRT-PCR using gene specific primers. Transfection efficiency of ( c ) SuvH39H1 -siRNAs and ( d ) Dnmt1 -siRNA was determined by quantifying its gene transcripts. NG and HG = cells in 5 mM or 20 mM D-glucose respectively, HG/ Suv -si and HG/ Dnmt1 -si = cells transfected with Suv39H1 -siRNA or Dnmt1 -siRNA, and incubated in 20 mM D-glucose, Suv -si and Dnmt -si = cells transfected with Suv39H1 -siRNA or Dnmt1 -siRNA. * p < 0.05 vs NG and # p < 0.05 vs HG.

Journal: Scientific Reports

Article Title: Regulation of Rac1 transcription by histone and DNA methylation in diabetic retinopathy

doi: 10.1038/s41598-021-93420-4

Figure Lengend Snippet: Regulation of Rac1 gene transcripts and 5hmC at its promoter. Cells transfected with Suv39H1 -siRNA ( Suv -si) or Dnmt1 -siRNA ( Dnmt -si), incubated in high glucose for four days, were analyzed for Rac1 ( a ) gene transcripts by qRT-PCR using β-actin as a housekeeping gene and ( b ) 5hmC at its promoter by immunoprecipitating 5hmC in the genomic DNA , and quantifying by qRT-PCR using gene specific primers. Transfection efficiency of ( c ) SuvH39H1 -siRNAs and ( d ) Dnmt1 -siRNA was determined by quantifying its gene transcripts. NG and HG = cells in 5 mM or 20 mM D-glucose respectively, HG/ Suv -si and HG/ Dnmt1 -si = cells transfected with Suv39H1 -siRNA or Dnmt1 -siRNA, and incubated in 20 mM D-glucose, Suv -si and Dnmt -si = cells transfected with Suv39H1 -siRNA or Dnmt1 -siRNA. * p < 0.05 vs NG and # p < 0.05 vs HG.

Article Snippet: A batch of HRECs from 6th-7th passage were transfected with two independent siRNA pools of Suv39H1 (Cat No: AM4611, siRNA ID: 117147; 117149, Thermofisher Scientific, Waltham, MA, USA) using LipofectamineTM RNAiMAX Transfection Reagent (Cat. No. 13778150, InvitrogenTM, Carlsbad, CA, USA) , or with Dnmt1- siRNA (Cat. No. SC-35204, Santa Cruz Biotechnology, Santa Cruz, CA, USA), using their transfection reagent (Cat. No. SC-29528, Santa Cruz Biotechnology).

Techniques: Transfection, Incubation, Quantitative RT-PCR

Effect of high glucose on localization of H3K9me3, Dnmt1 and Rac1. Immunofluorescence technique was used to determine co-localization of H3K9me3, Dnmt1 and Rac1 in HRECs. The images were captured by Zeiss microscope at 40 × magnification using the Apotome module. The line represents the region of interest used to quantify the arithmetic mean intensity per channel. The figure shows one representative cell/condition. Colors green, blue and red represent Dnmt1, Rac1 and H3K9me3, respectively.

Journal: Scientific Reports

Article Title: Regulation of Rac1 transcription by histone and DNA methylation in diabetic retinopathy

doi: 10.1038/s41598-021-93420-4

Figure Lengend Snippet: Effect of high glucose on localization of H3K9me3, Dnmt1 and Rac1. Immunofluorescence technique was used to determine co-localization of H3K9me3, Dnmt1 and Rac1 in HRECs. The images were captured by Zeiss microscope at 40 × magnification using the Apotome module. The line represents the region of interest used to quantify the arithmetic mean intensity per channel. The figure shows one representative cell/condition. Colors green, blue and red represent Dnmt1, Rac1 and H3K9me3, respectively.

Article Snippet: A batch of HRECs from 6th-7th passage were transfected with two independent siRNA pools of Suv39H1 (Cat No: AM4611, siRNA ID: 117147; 117149, Thermofisher Scientific, Waltham, MA, USA) using LipofectamineTM RNAiMAX Transfection Reagent (Cat. No. 13778150, InvitrogenTM, Carlsbad, CA, USA) , or with Dnmt1- siRNA (Cat. No. SC-35204, Santa Cruz Biotechnology, Santa Cruz, CA, USA), using their transfection reagent (Cat. No. SC-29528, Santa Cruz Biotechnology).

Techniques: Immunofluorescence, Microscopy

Gene expressions of Rac1, Suv39H1 and Dnmt1 in mouse retinal microvessels. Rac1, Suv39H1 and Dnmt1 gene transcripts were quantified by qRT-PCR using 18S as a housekeeping gene. The values are represented as mean ± SD of 5–6 mice/group, with each measurement made in duplicate. Norm and Diab = Normal and Diabetic mice; Diab/ Suv -si and Diab/ Dnmt1 -si = Mice receiving Suv39H1 -siRNA or Dnmt1 -siRNA, soon after induction of diabetes. * p < 0.05 compared to normal and # p < 0.05 compared to diabetes.

Journal: Scientific Reports

Article Title: Regulation of Rac1 transcription by histone and DNA methylation in diabetic retinopathy

doi: 10.1038/s41598-021-93420-4

Figure Lengend Snippet: Gene expressions of Rac1, Suv39H1 and Dnmt1 in mouse retinal microvessels. Rac1, Suv39H1 and Dnmt1 gene transcripts were quantified by qRT-PCR using 18S as a housekeeping gene. The values are represented as mean ± SD of 5–6 mice/group, with each measurement made in duplicate. Norm and Diab = Normal and Diabetic mice; Diab/ Suv -si and Diab/ Dnmt1 -si = Mice receiving Suv39H1 -siRNA or Dnmt1 -siRNA, soon after induction of diabetes. * p < 0.05 compared to normal and # p < 0.05 compared to diabetes.

Article Snippet: A batch of HRECs from 6th-7th passage were transfected with two independent siRNA pools of Suv39H1 (Cat No: AM4611, siRNA ID: 117147; 117149, Thermofisher Scientific, Waltham, MA, USA) using LipofectamineTM RNAiMAX Transfection Reagent (Cat. No. 13778150, InvitrogenTM, Carlsbad, CA, USA) , or with Dnmt1- siRNA (Cat. No. SC-35204, Santa Cruz Biotechnology, Santa Cruz, CA, USA), using their transfection reagent (Cat. No. SC-29528, Santa Cruz Biotechnology).

Techniques: Quantitative RT-PCR

Working model: Diabetes activates Suv39H1, and this increases H3K9me3 at Rac1 promoter, creating a mark on the chromatin for Dnmt1 binding. Concomitant activation of Dnmts and Tets hydroxymethylates 5mC to 5 hmC, facilitating the binding of the transcription factor and induction of Rac1 transcription. Activation of Rac1-Nox2-ROS damages the mitochondria, ultimately leading to the development of diabetic retinopathy.

Journal: Scientific Reports

Article Title: Regulation of Rac1 transcription by histone and DNA methylation in diabetic retinopathy

doi: 10.1038/s41598-021-93420-4

Figure Lengend Snippet: Working model: Diabetes activates Suv39H1, and this increases H3K9me3 at Rac1 promoter, creating a mark on the chromatin for Dnmt1 binding. Concomitant activation of Dnmts and Tets hydroxymethylates 5mC to 5 hmC, facilitating the binding of the transcription factor and induction of Rac1 transcription. Activation of Rac1-Nox2-ROS damages the mitochondria, ultimately leading to the development of diabetic retinopathy.

Article Snippet: A batch of HRECs from 6th-7th passage were transfected with two independent siRNA pools of Suv39H1 (Cat No: AM4611, siRNA ID: 117147; 117149, Thermofisher Scientific, Waltham, MA, USA) using LipofectamineTM RNAiMAX Transfection Reagent (Cat. No. 13778150, InvitrogenTM, Carlsbad, CA, USA) , or with Dnmt1- siRNA (Cat. No. SC-35204, Santa Cruz Biotechnology, Santa Cruz, CA, USA), using their transfection reagent (Cat. No. SC-29528, Santa Cruz Biotechnology).

Techniques: Binding Assay, Activation Assay

Primer sequences.

Journal: Scientific Reports

Article Title: Regulation of Rac1 transcription by histone and DNA methylation in diabetic retinopathy

doi: 10.1038/s41598-021-93420-4

Figure Lengend Snippet: Primer sequences.

Article Snippet: A batch of HRECs from 6th-7th passage were transfected with two independent siRNA pools of Suv39H1 (Cat No: AM4611, siRNA ID: 117147; 117149, Thermofisher Scientific, Waltham, MA, USA) using LipofectamineTM RNAiMAX Transfection Reagent (Cat. No. 13778150, InvitrogenTM, Carlsbad, CA, USA) , or with Dnmt1- siRNA (Cat. No. SC-35204, Santa Cruz Biotechnology, Santa Cruz, CA, USA), using their transfection reagent (Cat. No. SC-29528, Santa Cruz Biotechnology).

Techniques: Sequencing

Figure 1. 5hmC content is diluted during replication. A. Hemi-hydroxymethylated DNA (CG/5hmCG) is not a good substrate for Dnmt1. The DNA methylation activity of mouse Dnmt1, Dnmt3a, and Dnmt3b towards 35-bp unmethylated (CG/CG), hemi- methylated (CG/5mCG), or hemi-hydroxymethylated (CG/5hmCG) DNA was determined. B. Gel mobility shift assaying of the SRA domain of mouse Uhrf1. The indicated concentrations of SRA were incubated with either 12-bp CG/5mC, CG/5hmCG, or CG/CG, followed by electrophoresis (left panel). The complex of the SRA and 32P-labeled CG/5mCG was competed with the indicated amounts of non-labeled CG/5mCG, CG/5hmCG, or CG/CG DNA (right panel). DNA bound to SRA (B) and free DNA (F) are indicated.

Journal: PloS one

Article Title: Cell cycle-dependent turnover of 5-hydroxymethyl cytosine in mouse embryonic stem cells.

doi: 10.1371/journal.pone.0082961

Figure Lengend Snippet: Figure 1. 5hmC content is diluted during replication. A. Hemi-hydroxymethylated DNA (CG/5hmCG) is not a good substrate for Dnmt1. The DNA methylation activity of mouse Dnmt1, Dnmt3a, and Dnmt3b towards 35-bp unmethylated (CG/CG), hemi- methylated (CG/5mCG), or hemi-hydroxymethylated (CG/5hmCG) DNA was determined. B. Gel mobility shift assaying of the SRA domain of mouse Uhrf1. The indicated concentrations of SRA were incubated with either 12-bp CG/5mC, CG/5hmCG, or CG/CG, followed by electrophoresis (left panel). The complex of the SRA and 32P-labeled CG/5mCG was competed with the indicated amounts of non-labeled CG/5mCG, CG/5hmCG, or CG/CG DNA (right panel). DNA bound to SRA (B) and free DNA (F) are indicated.

Article Snippet: Solubilized chromatin was incubated with mouse monoclonal IgG (Cat No. 12-371, Millipore), rabbit IgG (Cat No. 12-370, Millipore), anti-Dnmt1 mouse monoclonal Dnmt1 (clone: 60B1220.1, Cat No. IMG-261A, Imgenex), anti-Dnmt3a/3a2 [5], anti-Dnmt3b [2], anti-Tet1 (Cat. No. 09-872, Millipore), antiTet2 (Cat No. R1086-6b, Abiocode), or anti-Tet3 (Cat. No. 61395, Activemotif) antibodies at 4°C overnight.

Techniques: DNA Methylation Assay, Activity Assay, Methylation, Mobility Shift, Incubation, Electrophoresis, Labeling

Figure 3. Dnmt3a and Dnmt3b mainly provide 5mC for the hydroxymethylation in mESCs. The 5mC, 5hmC, and Tet mRNA contents of J1 parent, Dnmt1 (1-KO), Dnmt3a and Dnmt3b (3-DKO), Dnmt3a (3a-KO), Dnmt3b (3b-KO), and Dnmt1, Dnmt3a and Dnmt3b (TKO) knockout mESCs, and ectopically expressed TAP-tagged Dnmt3a (3a-TAP) or Dnmt3a2 (3a2-TAP) in 3-DKO mESCs were determined. A. The 5mC contents (%) were determined as M.SssI methylation ability from a standard curve (Figure S1A). B. The 5hmC contents were determined from the standard curve obtained on β-GT assaying (Figure S1B). The values are the averages ± SD determined for three independent genomic DNA samples. C. Relative mRNA expression of Tet1, Tet2, and Tet3 was evaluated by semi-quantitative RT-PCR. (-) indicates the product of PCR without the template.

Journal: PloS one

Article Title: Cell cycle-dependent turnover of 5-hydroxymethyl cytosine in mouse embryonic stem cells.

doi: 10.1371/journal.pone.0082961

Figure Lengend Snippet: Figure 3. Dnmt3a and Dnmt3b mainly provide 5mC for the hydroxymethylation in mESCs. The 5mC, 5hmC, and Tet mRNA contents of J1 parent, Dnmt1 (1-KO), Dnmt3a and Dnmt3b (3-DKO), Dnmt3a (3a-KO), Dnmt3b (3b-KO), and Dnmt1, Dnmt3a and Dnmt3b (TKO) knockout mESCs, and ectopically expressed TAP-tagged Dnmt3a (3a-TAP) or Dnmt3a2 (3a2-TAP) in 3-DKO mESCs were determined. A. The 5mC contents (%) were determined as M.SssI methylation ability from a standard curve (Figure S1A). B. The 5hmC contents were determined from the standard curve obtained on β-GT assaying (Figure S1B). The values are the averages ± SD determined for three independent genomic DNA samples. C. Relative mRNA expression of Tet1, Tet2, and Tet3 was evaluated by semi-quantitative RT-PCR. (-) indicates the product of PCR without the template.

Article Snippet: Solubilized chromatin was incubated with mouse monoclonal IgG (Cat No. 12-371, Millipore), rabbit IgG (Cat No. 12-370, Millipore), anti-Dnmt1 mouse monoclonal Dnmt1 (clone: 60B1220.1, Cat No. IMG-261A, Imgenex), anti-Dnmt3a/3a2 [5], anti-Dnmt3b [2], anti-Tet1 (Cat. No. 09-872, Millipore), antiTet2 (Cat No. R1086-6b, Abiocode), or anti-Tet3 (Cat. No. 61395, Activemotif) antibodies at 4°C overnight.

Techniques: Knock-Out, Methylation, Expressing, Quantitative RT-PCR

Figure 5. Dnmt3a and Dnmt3b-dependent 5mC are responsible for the production of 5hmC. The 5hmC (A) and 5mC (B) contents of J1 (blue bars), Dnmt1 (1-KO, red bars), and Dnmt3a and Dnmt3b (3-DKO, light green bars) knockout mESCs were determined by q-PCR in the promoters of five representative 5hmC-enriched genes. The values are the averages + SD determined for three independent genomic DNA samples.

Journal: PloS one

Article Title: Cell cycle-dependent turnover of 5-hydroxymethyl cytosine in mouse embryonic stem cells.

doi: 10.1371/journal.pone.0082961

Figure Lengend Snippet: Figure 5. Dnmt3a and Dnmt3b-dependent 5mC are responsible for the production of 5hmC. The 5hmC (A) and 5mC (B) contents of J1 (blue bars), Dnmt1 (1-KO, red bars), and Dnmt3a and Dnmt3b (3-DKO, light green bars) knockout mESCs were determined by q-PCR in the promoters of five representative 5hmC-enriched genes. The values are the averages + SD determined for three independent genomic DNA samples.

Article Snippet: Solubilized chromatin was incubated with mouse monoclonal IgG (Cat No. 12-371, Millipore), rabbit IgG (Cat No. 12-370, Millipore), anti-Dnmt1 mouse monoclonal Dnmt1 (clone: 60B1220.1, Cat No. IMG-261A, Imgenex), anti-Dnmt3a/3a2 [5], anti-Dnmt3b [2], anti-Tet1 (Cat. No. 09-872, Millipore), antiTet2 (Cat No. R1086-6b, Abiocode), or anti-Tet3 (Cat. No. 61395, Activemotif) antibodies at 4°C overnight.

Techniques: Knock-Out

Figure 6. Dnmt1, Dnmt3a, Dnmt3b, and Tet1 are recruited to 5hmC-enriched promoters. The occupancy of Dnmt1, Dnmt3a, and Dnmt3b (A), and Tet1, Tet2, and Tet3 (B) was determined by ChIP-qPCR in the promoters of the 5hmC- enriched genes shown in Figure 4. The values are the averages + SD determined for three independent DNA samples.

Journal: PloS one

Article Title: Cell cycle-dependent turnover of 5-hydroxymethyl cytosine in mouse embryonic stem cells.

doi: 10.1371/journal.pone.0082961

Figure Lengend Snippet: Figure 6. Dnmt1, Dnmt3a, Dnmt3b, and Tet1 are recruited to 5hmC-enriched promoters. The occupancy of Dnmt1, Dnmt3a, and Dnmt3b (A), and Tet1, Tet2, and Tet3 (B) was determined by ChIP-qPCR in the promoters of the 5hmC- enriched genes shown in Figure 4. The values are the averages + SD determined for three independent DNA samples.

Article Snippet: Solubilized chromatin was incubated with mouse monoclonal IgG (Cat No. 12-371, Millipore), rabbit IgG (Cat No. 12-370, Millipore), anti-Dnmt1 mouse monoclonal Dnmt1 (clone: 60B1220.1, Cat No. IMG-261A, Imgenex), anti-Dnmt3a/3a2 [5], anti-Dnmt3b [2], anti-Tet1 (Cat. No. 09-872, Millipore), antiTet2 (Cat No. R1086-6b, Abiocode), or anti-Tet3 (Cat. No. 61395, Activemotif) antibodies at 4°C overnight.

Techniques: ChIP-qPCR

Methylation-dependent silencing of KDM2B expression. (A) LCL were cultured for 96 h in the presence of DMSO (nontreated [NT]) or 5-aza-2′-deoxycytidine (Aza). Cells were then collected, and the KDM2B expression levels were analyzed by RT-qPCR. The histogram shows the average KDM2B mRNA levels measured in 3 independent experiments (*, P < 0.05). KDM2B mRNA levels in Aza-treated LCL were measured relative to its levels in DMSO-treated cells. (B) LCL were transfected with stabilized siRNA targeting DNMT1 (siDNMT1) in two independent experiments. At 4 days after transfection, cells were collected and analyzed for the protein levels of DNMT1 (top) and the mRNA levels of KDM2B (bottom). KDM2B mRNA levels in DNMT1-targeted siRNA-treated cells were measured relative to its levels in cells treated with scrambled (scr) siRNA. (C) RPMI cells infected with EBV or mock infected were fixed and processed for ChIP with a DNMT1 antibody or an IgG antibody as a negative control. The eluted DNA was analyzed by qPCR with primers flanking CpG15695155, CpG21423404, and CpG island 127 (primer sequences are described in Table 3) (*, P < 0.05; ns, not significant).

Journal: Journal of Virology

Article Title: Interplay between the Epigenetic Enzyme Lysine (K)-Specific Demethylase 2B and Epstein-Barr Virus Infection

doi: 10.1128/JVI.00273-19

Figure Lengend Snippet: Methylation-dependent silencing of KDM2B expression. (A) LCL were cultured for 96 h in the presence of DMSO (nontreated [NT]) or 5-aza-2′-deoxycytidine (Aza). Cells were then collected, and the KDM2B expression levels were analyzed by RT-qPCR. The histogram shows the average KDM2B mRNA levels measured in 3 independent experiments (*, P < 0.05). KDM2B mRNA levels in Aza-treated LCL were measured relative to its levels in DMSO-treated cells. (B) LCL were transfected with stabilized siRNA targeting DNMT1 (siDNMT1) in two independent experiments. At 4 days after transfection, cells were collected and analyzed for the protein levels of DNMT1 (top) and the mRNA levels of KDM2B (bottom). KDM2B mRNA levels in DNMT1-targeted siRNA-treated cells were measured relative to its levels in cells treated with scrambled (scr) siRNA. (C) RPMI cells infected with EBV or mock infected were fixed and processed for ChIP with a DNMT1 antibody or an IgG antibody as a negative control. The eluted DNA was analyzed by qPCR with primers flanking CpG15695155, CpG21423404, and CpG island 127 (primer sequences are described in Table 3) (*, P < 0.05; ns, not significant).

Article Snippet: The following antibodies were used: KDM2B (catalog number ab5199; Abcam), DNMT1 (catalog number MAB0079; Abnova), and IgG (Diagenode).

Techniques: Methylation, Expressing, Cell Culture, Quantitative RT-PCR, Transfection, Infection, Negative Control

Primers used for qPCR and ChIP-qPCR

Journal: Journal of Virology

Article Title: Interplay between the Epigenetic Enzyme Lysine (K)-Specific Demethylase 2B and Epstein-Barr Virus Infection

doi: 10.1128/JVI.00273-19

Figure Lengend Snippet: Primers used for qPCR and ChIP-qPCR

Article Snippet: The following antibodies were used: KDM2B (catalog number ab5199; Abcam), DNMT1 (catalog number MAB0079; Abnova), and IgG (Diagenode).

Techniques: Sequencing

LMP1 mediates downregulation of KDM2B. (A) RPMI cells were stably transduced with pLXSN or with pLXSN-LMP1 (LMP1) in four independent transduction experiments. Cells were then collected, and the expression levels of LMP1 (left) and KDM2B (right) were analyzed by RT-qPCR (****, P < 0.0001). (B) RPMI-pLXSN or RPMI-LMP1 cells were cultured in the presence of Aza (+) or DMSO (−) for 48 h, and the KDM2B mRNA expression level was analyzed by RT-qPCR. The histogram shows the average from 2 independent experiments (*, P < 0.05; ns, not significant). (C and D) Louckes cells were stably transduced with pLXSN, pLXSN-LMP1 (LMP1), or pLXSN-LMP1 mutants (3AAA, 378, and 3AAA/378). Cells were collected and processed for RNA and protein analysis. mRNA expression and protein levels of LMP1 were detected by RT-PCR (C, top) and immunoblotting (C, bottom). KDM2B mRNA and protein levels were also shown by RT-qPCR and immunoblotting, respectively (D, left and right). In panel D, the difference between KDM2B mRNA and protein levels in Louckes cells with pLXSN and in Louckes cells stably expressing wild-type LMP1 was significant (*, P < 0.05; **, P < 0.01). The levels of KDM2B mRNA in cells expressing wild-type (WT) LMP1 and LMP1 mutants were measured relative to its level in cells expressing pLXSN. (E) RPMI-LMP1 cells were treated for 2 h with BAY11-7082 (Bay11) (10 μM) or with JNK inhibitor II (JNKII) (10 μM) in three independent experiments. KDM2B mRNA levels were analyzed by RT-qPCR (*, P < 0.05). (F) RPMI pLXSN and RPMI-LMP1 cells, the latter of which were untreated or treated with BAY11-7082 (10 μM) for 2 h, were fixed to perform ChIP with DNMT1 or IgG antibodies. The eluted DNA was analyzed by qPCR with primers designed to surround CpG21423404. The histogram shows the average percentage of recruitment of DNMT1 in 4 independent experiments (*, P < 0.05).

Journal: Journal of Virology

Article Title: Interplay between the Epigenetic Enzyme Lysine (K)-Specific Demethylase 2B and Epstein-Barr Virus Infection

doi: 10.1128/JVI.00273-19

Figure Lengend Snippet: LMP1 mediates downregulation of KDM2B. (A) RPMI cells were stably transduced with pLXSN or with pLXSN-LMP1 (LMP1) in four independent transduction experiments. Cells were then collected, and the expression levels of LMP1 (left) and KDM2B (right) were analyzed by RT-qPCR (****, P < 0.0001). (B) RPMI-pLXSN or RPMI-LMP1 cells were cultured in the presence of Aza (+) or DMSO (−) for 48 h, and the KDM2B mRNA expression level was analyzed by RT-qPCR. The histogram shows the average from 2 independent experiments (*, P < 0.05; ns, not significant). (C and D) Louckes cells were stably transduced with pLXSN, pLXSN-LMP1 (LMP1), or pLXSN-LMP1 mutants (3AAA, 378, and 3AAA/378). Cells were collected and processed for RNA and protein analysis. mRNA expression and protein levels of LMP1 were detected by RT-PCR (C, top) and immunoblotting (C, bottom). KDM2B mRNA and protein levels were also shown by RT-qPCR and immunoblotting, respectively (D, left and right). In panel D, the difference between KDM2B mRNA and protein levels in Louckes cells with pLXSN and in Louckes cells stably expressing wild-type LMP1 was significant (*, P < 0.05; **, P < 0.01). The levels of KDM2B mRNA in cells expressing wild-type (WT) LMP1 and LMP1 mutants were measured relative to its level in cells expressing pLXSN. (E) RPMI-LMP1 cells were treated for 2 h with BAY11-7082 (Bay11) (10 μM) or with JNK inhibitor II (JNKII) (10 μM) in three independent experiments. KDM2B mRNA levels were analyzed by RT-qPCR (*, P < 0.05). (F) RPMI pLXSN and RPMI-LMP1 cells, the latter of which were untreated or treated with BAY11-7082 (10 μM) for 2 h, were fixed to perform ChIP with DNMT1 or IgG antibodies. The eluted DNA was analyzed by qPCR with primers designed to surround CpG21423404. The histogram shows the average percentage of recruitment of DNMT1 in 4 independent experiments (*, P < 0.05).

Article Snippet: The following antibodies were used: KDM2B (catalog number ab5199; Abcam), DNMT1 (catalog number MAB0079; Abnova), and IgG (Diagenode).

Techniques: Stable Transfection, Transduction, Expressing, Quantitative RT-PCR, Cell Culture, Reverse Transcription Polymerase Chain Reaction, Western Blot

TIP60 interferes with UHRF1-USP7 association and their expression levels. HeLa cells were transfected with either TIP60-eGFP WT or TIP60ΔMYST-eGFP mutant. Western blot and immunoprecipitated samples were resolved by SDS-PAGE and immunoblotted with anti-UHRF1, anti-USP7 and anti-DNMT1 antibodies. (A) Effect of TIP60 on UHRF1, USP7 and DNMT1 levels with or without MG-132 treatment, respectively. (B and C) Quantification of the effect of TIP60 on UHRF1, USP7 and DNMT1 levels with or without MG-132 treatment, respectively. Values are the mean ± SEM from at least three independent experiments which were analyzed statistically by one-way ANOVA with Tukey's post hoc test ( * P<0.05; *** P<0.001 vs. control group). (D) Anti-UHRF1 antibody was used to co-immunoprecipitate UHRF1 and its partner USP7. (E) In a reciprocal experiment, anti-USP7 antibody was used to co-immunoprecipitate USP7 and UHRF1. Inputs and IP gels were processed in parallel under similar conditions. UHRF1, ubiquitin-like, containing PHD and RING finger domains 1; TIP60, Tat interactive protein, 60 kDa; USP7, ubiquitin-specific-processing protease 7; DNMT1, DNA methyltransferase 1.

Journal: International Journal of Oncology

Article Title: TIP60 governs the auto-ubiquitination of UHRF1 through USP7 dissociation from the UHRF1/USP7 complex

doi: 10.3892/ijo.2021.5269

Figure Lengend Snippet: TIP60 interferes with UHRF1-USP7 association and their expression levels. HeLa cells were transfected with either TIP60-eGFP WT or TIP60ΔMYST-eGFP mutant. Western blot and immunoprecipitated samples were resolved by SDS-PAGE and immunoblotted with anti-UHRF1, anti-USP7 and anti-DNMT1 antibodies. (A) Effect of TIP60 on UHRF1, USP7 and DNMT1 levels with or without MG-132 treatment, respectively. (B and C) Quantification of the effect of TIP60 on UHRF1, USP7 and DNMT1 levels with or without MG-132 treatment, respectively. Values are the mean ± SEM from at least three independent experiments which were analyzed statistically by one-way ANOVA with Tukey's post hoc test ( * P<0.05; *** P<0.001 vs. control group). (D) Anti-UHRF1 antibody was used to co-immunoprecipitate UHRF1 and its partner USP7. (E) In a reciprocal experiment, anti-USP7 antibody was used to co-immunoprecipitate USP7 and UHRF1. Inputs and IP gels were processed in parallel under similar conditions. UHRF1, ubiquitin-like, containing PHD and RING finger domains 1; TIP60, Tat interactive protein, 60 kDa; USP7, ubiquitin-specific-processing protease 7; DNMT1, DNA methyltransferase 1.

Article Snippet: Other antibodies used included rabbit polyclonal anti-HAUSP/USP7 (1:5,000; cat. no. ab4080, Abcam), mouse monoclonal anti-DNMT1 (1:5,000; cat. no. PTG-MAB0079, ProteoGenix), mouse monoclonal anti-ubiquitin (1:500; cat. no. 05-944, Sigma-Aldrich; Merck KGaA), mouse monoclonal eGFP (1:1,000; cat. no. 66,002-1-Ig, Proteintech Group, Inc.; and cat. no. A-11120, Thermo Fisher Scientific, Inc.), mouse monoclonal anti-GAPDH (1:5,000; cat. no. MAB374, Merck KGaA), mouse monoclonal anti-GFP (1:1,000; cat. no. 66002-1-Ig, Proteintech Group, Inc.), mouse monoclonal anti-p73 (1:500; cat. no. 558785, BD Biosciences), rabbit polyclonal anti-caspase-3 (1:1,000; cat. no. 9661, Cell Signaling Technology, Inc.), mouse monoclonal anti-BCL2 (1:1,000; cat. no. 05-826, Merck KGaA), mouse monoclonal anti-poly(ADP-ribose) polymerase (PARP; 1:1,000; cat. no. 51-6639GR, BD Biosciences) and rabbit polyclonal anti-BAX (1:1,000; cat. no. AB2930, Merck KGaA).

Techniques: Expressing, Transfection, Mutagenesis, Western Blot, Immunoprecipitation, SDS Page